Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117340) titled 'A Retrospective Study Comparing Tofacitinib with Antihistamines in the Treatment of Cholinergic Urticaria and Symptomatic Dermographism' on Jan. 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Dermatology Hospital of Southern Medical University
Condition:
Chronic urticaria
Intervention:
Tofacitinib groups:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-15
Target Sample Size: Tofacitinib groups:10;Antihistamine group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301927
Disclaim...